News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Vivek Subbiah: Obinutuzumab in Active Lupus Nephritis is a nice example of drug repurposing
Vivek Subbiah/LinkedIn
Apr 20, 2025, 09:19

Vivek Subbiah: Obinutuzumab in Active Lupus Nephritis is a nice example of drug repurposing

Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute (USA), shared an article by Richard A. Furie, et al. on X:

“Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis:

Obinutuzumab = a humanized type II anti-CD20 monoclonal antibody approved in CLL.

A nice example of drug repurposing.”

Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis.

Authors: Richard A. Furie, et al.

Vivek Subbiah: Obinutuzumab in Active Lupus Nephritis is a nice example of drug repurposing

Active Lupus Nephritis cancer CLL drug repurposing early-phase drug development fight against cancer Global fight against cancer Monoclonal Antibody Obinutuzumab OncoDaily Oncology Sarah Cannon Research Institute Vivek Subbiah
Special Coverage
Oncolibrary
May 11, 2025, 13:51
FDA Grants Accelerated Approval to Avutometinib and Defactinib for KRAS-Mutated Recurrent Low-Grade Serous Ovarian Cancer: RAMP 201 trial results
Blog
May 11, 2025, 13:41
In Palliative Care and Beyond, a Mother’s Love is a Healing Force - ACREOL Global
Blog
May 11, 2025, 13:29
Freddy E Escorcia: Departure from NCI After Nearly Nine Years
Blog
May 11, 2025, 13:13
Shahrin Ahmed: Are Breast Cancer Outcomes in Women Improved by RiskScore Testing?
Blog
May 11, 2025, 12:41
Aria Vaishnavi: First Preprint From My Lab on ERBB Signaling in BRAFV600E-Driven Lung Cancer
Insight
May 11, 2025, 12:06
Bobby Koneru: First Modern American Case Series on Treating Osteoarthritis with Low-Dose Radiotherapy
Blog
May 11, 2025, 11:55
Filippo Alongi: Radiotherapy Innovation Recognized at ESTRO 2025
Blog
May 11, 2025, 11:48
Stephen V Liu: Yilong Wu shows the Potential of PD1/VEGF Bispecifics in driver positive NSCLC at RomeLung25
Insight
May 11, 2025, 11:37
Aman Chauhan: Latest ASCO guidelines on functional Neuroendocrine Tumors (NETs)
Blog
May 11, 2025, 11:35
Helena Linardou: Visionary lecture from Faisal Mahmood here at AI for Oncology
Blog
May 11, 2025, 11:29
Kenji López-Cuevas: Forum for Cancer Care Planners 2025
Blog
May 11, 2025, 11:17
Katie Coleman Launches Cancer Screening and Risk Assessment App Hackathon